Author Affiliations: Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Md (Dr Blumenthal); and Evaluation and Research Technologies for Health Inc, Oakland, Calif (Dr Gaffikin).
Cervical cancer is unique for several reasons. It has recognized, well-described risk factors; there is an identifiable precancerous condition; the transition from precancer to cancer occurs over an extended period (10 years on average)1; screening tests for detecting cancer and precancer exist; and outpatient treatments for precancer are safe, effective, and relatively inexpensive.
Blumenthal PD, Gaffikin L. Cervical Cancer PreventionMaking Programs More Appropriate and Pragmatic. JAMA. 2005;294(17):2225-2228. doi:10.1001/jama.294.17.2225